Home Featured Page 126

Featured

Latest

Areyto Boriken – Ethnobotanical Adventure

The Ram Dass Institute of Psychedelic Studies with The Dying Inaugural Event on Maui

International Conference on Assisted Dying and Other End of Life Care (ICEL5)

Michael Ryoshin Sapiro, PsyD – Truth Medicine, Psychedelics, and Living Your Truth

What the Cancer Community Actually Needs from Psychedelic Care

Ehave Shareholder from CEO Ben Kaplan and Corporate Update

Braxia Scientific Reports Q2 2023 Financial Results; Focused on Growing Clinic...

Psyence Group Announces Closing of Second Tranche of Private Placement and...

Israeli Based Biotech Company Clearmind Completes IND-Enabling Studies for CMND-100

Vital 2023: Informational Session and Q&A

Psychedelic Health – New course launches to bridge the psychedelic education...

Vice – How to Microdose Drugs Based on What You’re Using

Psychedelic Spotlight – The Top 5 Psychedelics Podcasts

Lucid News – Psychedelic Therapy Training Programs Expand To Meet Demand

Mydecine Innovations Group Closes Sale of Its Wholly-Owned Subsidiary, Mindleap Health...

1...125126127...303 Page 126 of 303

Areyto Boriken – Ethnobotanical Adventure

The Ram Dass Institute of Psychedelic Studies with The Dying Inaugural...

International Conference on Assisted Dying and Other End of Life Care...

How to Get DMT: Obtaining the Spirit Molecule

Having Sex on DMT: What You Need to Know

DMT Pricing Guide

ABOUT US

PsyNews.com has a single-sector focus. We are a news platform dedicated to covering the psychedelic industry. This includes companies, startups, venture capital firms, investment banks, pharma, research, etc, anything associated with the new emerging industry and asset class. Many of the chemicals and compounds involved are LSD, psilocybin, DMT, ketamine, MDMA, ecstasy, ibogaine, analogs, derivatives, psychedelic mushrooms, fungi, psilocin, entheogens, empathogens, indocybin, magic truffles (psilocybin sclerotia), etc. They range from classical and standard to new and exotic. PsyNews.com will cover all psychedelic news in the psy industry, including current events, updates, and what’s happening everywhere in the sector in term of developments and investments. We will be tracking companies worth, valuation, ROI, financials, stock, revenue, IPO’s, and more. Along with medical, recreational, clinical trials, FDA, mindfulness, psy space, 5-HT2A receptor experiments, and so forth. Join us on an unforgettable journey to the center of the psychedelic industry.

Featured

Areyto Boriken – Ethnobotanical Adventure

The Ram Dass Institute of Psychedelic Studies with The Dying Inaugural Event on Maui

International Conference on Assisted Dying and Other End of Life Care (ICEL5)

Michael Ryoshin Sapiro, PsyD – Truth Medicine, Psychedelics, and Living Your Truth

What the Cancer Community Actually Needs from Psychedelic Care

Ehave Shareholder from CEO Ben Kaplan and Corporate Update

Braxia Scientific Reports Q2 2023 Financial Results; Focused on Growing Clinic...

Psyence Group Announces Closing of Second Tranche of Private Placement and...

Israeli Based Biotech Company Clearmind Completes IND-Enabling Studies for CMND-100

Vital 2023: Informational Session and Q&A

Psychedelic Health – New course launches to bridge the psychedelic education...

Vice – How to Microdose Drugs Based on What You’re Using

Psychedelic Spotlight – The Top 5 Psychedelics Podcasts

Lucid News – Psychedelic Therapy Training Programs Expand To Meet Demand

Mydecine Innovations Group Closes Sale of Its Wholly-Owned Subsidiary, Mindleap Health...

EDITOR PICKS

Areyto Boriken – Ethnobotanical Adventure

The Ram Dass Institute of Psychedelic Studies with The Dying Inaugural...

International Conference on Assisted Dying and Other End of Life Care...

POPULAR POSTS

How to Get DMT: Obtaining the Spirit Molecule

Having Sex on DMT: What You Need to Know

DMT Pricing Guide

POPULAR CATEGORY